Longer-term RBC transfusion reduction in the phase III MEDALIST study of luspatercept in patients (pts) with lower-risk MDS with ring sideroblasts (RS).

被引：0
|
作者：
Komrokji, Rami S.
Sekeres, Mikkael A.
Zeidan, Amer Methqal
Fenaux, Pierre
List, Alan F.
Dezern, Amy Elizabeth
Greenberg, Peter L.
Savona, Michael R.
Jurcic, Joseph G.
Verma, Amit
Mufti, Ghulam J.
Buckstein, Rena
Santini, Valeria
Laadem, Abderrahmane
Ito, Rodrigo
Zhang, Jennie
Louis, Chrystal Ursula
Linde, Peter G.
Garcia-Manero, Guillermo
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Cleveland Clin, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
[3] Yale Univ, Yale Sch Med, Dept Internal Med, New Haven, CT USA
[4] Yale Univ, Yale Canc Ctr, Dept Internal Med, New Haven, CT USA
[5] Univ Paris 07, Serv Hematol Seniors, Hop St Louis, Paris, France
[6] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[7] Stanford Univ, Canc Ctr, Stanford, CA 94305 USA
[8] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA
[9] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Div Hematol Oncol, Med Ctr, New York, NY USA
[10] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Oncol, Bronx, NY 10467 USA
[11] Kings Coll London, Dept Haematooncol, London, England
[12] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[13] Univ Florence, Azienda Osped Univ AOU Careggi, MDS Unit, Florence, Italy
[14] Bristol Myers Squibb, Summit, NJ USA
[15] Acceleron Pharma, Cambridge, MA USA
[16] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7518
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Longer-Term RBC Transfusion Reduction in the Phase III MEDALIST Study of Luspatercept in Patients With Lower-Risk MDS With Ring Sideroblasts
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 14 - 14
  • [2] Longer-Term RBC Transfusion Reduction in the Phase 3 MEDALIST Study of Luspatercept in Patients with Lower-Risk MDS (LR-MDS) with Ring Sideroblasts (RS)
    Komrokji, Rami S.
    Sekeres, Mikkael A.
    Zeidan, Amer M.
    Fenaux, Pierre
    Platzbecker, Uwe
    DeZern, Amy E.
    Greenberg, Peter L.
    Savona, Michael R.
    Jurcic, Joseph G.
    Verma, Amit
    Mufti, Ghulam J.
    Buckstein, Rena
    Santini, Valeria
    Laadem, Abderrahmane
    Ito, Rodrigo
    Zhang, Jennie
    Louis, Chrystal U.
    Linde, Peter G.
    Garcia-Manero, Guillermo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S322 - S322
  • [3] Longer-term RBC transfusion reduction in the phase 3 MEDALIST study of luspatercept in patients (pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) with Ring Sideroblasts (RS)
    Platzbecker, U.
    Giagounidis, A.
    Heuser, M.
    Goetze, K.
    Thol, F.
    Fenaux, P.
    Komrokji, R. S.
    Laadem, A.
    Ito, R.
    Rampersad, A.
    Zhang, J.
    Louis, C. U.
    Germing, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 169 - 169
  • [4] Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts
    Zeidan, Amer M.
    Platzbecker, Uwe
    Garcia-Manero, Guillermo
    Sekeres, Mikkael A.
    Fenaux, Pierre
    DeZern, Amy E.
    Greenberg, Peter L.
    Savona, Michael R.
    Jurcic, Joseph G.
    Verma, Amit K.
    Mufti, Ghulam J.
    Buckstein, Rena
    Santini, Valeria
    Shetty, Jeevan K.
    Ito, Rodrigo
    Zhang, Jennie
    Zhang, George
    Ha, Xianwei
    Backstrom, Jay T.
    Komrokji, Rami S.
    BLOOD, 2022, 140 (20) : 2170 - 2174
  • [5] Clinical Benefit of Luspatercept in Patients With Lower-Risk MDS and High Transfusion Burden in the Phase III MEDALIST Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 7 - 9
  • [6] Clinical benefit of luspatercept in patients (pts) with lower-risk MDS (LR-MDS) and high transfusion burden in the phase III MEDALIST study.
    Zeidan, Amer Methqal
    Garcia-Manero, Guillermo
    Dezern, Amy Elizabeth
    Fenaux, Pierre
    Greenberg, Peter L.
    Savona, Michael R.
    Jurcic, Joseph G.
    Verma, Amit
    Mufti, Ghulam J.
    Buckstein, Rena
    Santini, Valeria
    Laadem, Abderrahmane
    Zhang, Jennie
    Rampersad, Anita
    Sinsimer, Daniel
    Louis, Chrystal Ursula
    Linde, Peter G.
    List, Alan F.
    Sekeres, Mikkael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Assessment of dose-dependent response to luspatercept in patients (pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) with Ring Sideroblasts (RS) in the phase 3 MEDALIST trial
    Platzbecker, U.
    Germing, U.
    Goetze, K.
    Heuser, M.
    Thol, F.
    Fenaux, P.
    Komrokji, R. S.
    Laadem, A.
    Ito, R.
    Zhang, J.
    Rampersad, A.
    Morison, J.
    Louis, C. U.
    Giagounidis, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 171 - 171
  • [8] Effects of Luspatercept on Serum Ferritin in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) with Ring Sideroblasts (RS) in the Phase 3 MEDALIST Trial
    Fenaux, Pierre
    Santini, Valeria
    Mufti, Ghulam J.
    Diez-Campelo, Maria
    Finelli, Carlo
    Sekeres, Mikkael A.
    Quesnel, Bruno
    Beyne-Rauzy, Odile
    Garcia-Manero, Guillermo
    Komrokji, Rami S.
    Buckstein, Rena
    Voso, Maria Teresa
    Selleslag, Dominik
    DeZern, Amy E.
    Greenberg, Peter L.
    Zeidan, Amer M.
    Ades, Lionel
    Verma, Amit
    Savona, Michael R.
    Laadem, Abderrahmane
    Ito, Rodrigo
    Zhang, Jennie
    Rampersad, Anita
    Sinsimer, Daniel
    Morison, Jessica
    Louis, Chrystal
    Linde, Peter G.
    Platzbecker, Uwe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S317 - S317
  • [9] Multiple periods of transfusion independence (TI) with luspatercept (LUSP) treatment (Tx) and the impact of dose escalation in patients (Pts) with lower-risk myelodysplastic syndromes (LR-MDS) with ring sideroblasts (RS) from the MEDALIST study
    Platzbecker, U.
    Santini, V
    Komrokji, R. S.
    Zeidan, A. M.
    Garcia-Manero, G.
    Buckstein, R. J.
    Oliva, E. N.
    Pozharskaya, V
    Nadal, J. A.
    Miteva, D.
    Fenaux, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 18 - 19
  • [10] Assessment of Dose-Dependent Response to Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) with Ring Sideroblasts (RS) in the Phase 3 MEDALIST Trial
    Platzbecker, Uwe
    Fenaux, Pierre
    Mufti, Ghulam J.
    Garcia-Manero, Guillermo
    Komrokji, Rami S.
    Buckstein, Rena
    Diez-Campelo, Maria
    Finelli, Carlo
    Sekeres, Mikkael A.
    Selleslag, Dominik
    DeZern, Amy E.
    Quesnel, Bruno
    Beyne-Rauzy, Odile
    Voso, Maria Teresa
    Greenberg, Peter L.
    Zeidan, Amer M.
    Ades, Lionel
    Verma, Amit
    Savona, Michael R.
    Laadem, Abderrahmane
    Ito, Rodrigo
    Zhang, Jennie
    Rampersad, Anita
    Morison, Jessica
    Louis, Chrystal
    Linde, Peter G.
    Santini, Valeria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S318 - S318
12345